Characteristics of previous studies.

aColon cancer patients, bRectal cancer patients, c403 cases are discovery cohort and 151 cases are validation cohort, each cohort selected from different center, dFollicular lymphoma patients, eDiffuse large B-cell lymphoma patients, fPatients who had undergone pancreatic resection operation, gPatients whose cancer locally advanced, hPatients whose cancer had metastasized, iMedian survival time, jOS, overall survival; DFS, disease free survival; RFS, relapse free survival; EFS, event free survival; DMFS, distant metastasis-free survival; BCSS, breast cancer specific survival, kAJCC, american joint committee on cancer; KPS, karnofski performance status; ECOG, eastern cooperative oncology group; CCRT, concurrent neoadjuvant chemoradiotherapy; FIGO, international federation of gynecology and obstetric.